Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 50 mg/vial - caspofungin - indicated in adults and pediatric patients (3 months and older) for: - empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). has not been studied as initial therapy for invasive aspergillosis.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 70 mg/vial - caspofungin - indicated in adults and pediatric patients (3 months and older) for: - empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). has not been studied as initial therapy for invasive aspergillosis.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - travoprost - ophthalmic solution - travoprost 0.04 mg/ml - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dorzolamide as hydrochloride - eye drops, solution - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide s.k. is indicated for the treatment of eleveated intraocular pressure in patients with ocular hypertension, openangle glaucoma and in some patients secondary glaucoma.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - fulvestrant - solution for injection - fulvestrant 50 mg/ml - fulvestrant - monotherapy fulvestrant is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women: not previously treated with endocrine therapy, or - with disease relapse on or after adjuvant endocrine therapy; or - disease progression on endocrine therapy combination therapy fulvestrant is indicated for the treatment of: - hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in men and postmenopausal women in combination with ribociclib as initial endocrine based therapy or following disease progression on endocrine therapy. - hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - arsenic trioxide - concentrate for solution for infusion - arsenic trioxide 1 mg / 1 ml - arsenic trioxide - arsenic trioxide s.k. is indicated for induction of remission, and consolidation in adult patients with: •newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10x1000µl incombination with all-trans-retinoic acid (atra) •relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 10 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 15 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 20 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.

Iżrael - Ingliż - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dexmethylphenidate hydrochloride - capsules extended release - dexmethylphenidate hydrochloride 30 mg - dexmethylphenidate - metadex xr extended-release capsules are a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults.